The Editor-in-Chief has been alerted to concerns regarding the ethical and regulatory approval for the research described in this article.1 The journal has not been able to obtain verification from the authors or responsible institution regarding these concerns. This expression of concern alerts readers to the possibility that this research may have been conducted without appropriate ethical and/or regulatory approval. Appropriate editorial action will be taken if and when further information becomes available.
Article contents
Emergence of NDM-producing Pseudomonas aeruginosa among hospitalized patients and impact on antimicrobial therapy during the coronavirus disease 2019 (COVID-19) pandemic – EXPRESSION OF CONCERN
Published online by Cambridge University Press: 16 September 2022
Abstract
An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.
- Type
- Corrigendum
- Information
- Copyright
- © The Author(s), 2022. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America.
References
Perez, LRR, Carniel, E, Narvaez, GA. (2006) 40Ar/39Ar Emergence of NDM-producing Pseudomonas aeruginosa among hospitalized patients and impact on antimicrobial therapy during the coronavirus disease 2019 (COVID-19) pandemic. Infect Control Hosp Epidemiol 2021 June 28:1-3. doi: 10.1017/ice.2021.253
CrossRefGoogle Scholar
This correction applies to the following article(s):
You have
Access
- 1
- Cited by